Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

Background The relationship between baseline C-reactive protein (CRP) level and the
prognosis of cancer patients receiving immune checkpoint inhibitor (ICI) treatment remains …

Importance The association of chronic inflammation with colorectal cancer recurrence and
death is not well understood, and data from large well-designed prospective cohorts are …

C-reactive protein (CRP) has been studied extensively for association with a large number
of non-infectious diseases and outcomes. We aimed to evaluate the breadth and validity of …

Background The prognostic effect of elevated systemic inflammatory markers, including
neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), remains …

Objective To perform a meta-analysis of prospective and retrospective studies exploring the
association of the modified Glasgow prognostic score (mGPS) with overall survival (OS) in …

Cancer immunotherapy has emerged as a novel and effective treatment strategy for several
types of cancer. Immune checkpoint inhibitors (ICIs) have recently demonstrated impressive …

Backgrounds The inflammatory biomarker “C-reactive protein to albumin ratio (CAR)” has
been reported to significantly correlate to a variety of human cancers. However, there are …

Objective We assessed the effect of surgical resection of colorectal cancer (CRC) on
perioperative plasma vitamin D (25OHD) and C-reactive protein (CRP) level. We …

Background: There has been an increasing interest in the role of tumour location in the
treatment and prognosis of patients with colorectal cancer (CRC), specifically in the adjuvant …